This publication reports on newly diagnosed cancers registered in England in addition to cancer deaths registered in England during 2020. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document.

In 2022, 83.2 males and 69.3 females per 100,000 population in England were registered as newly diagnosed with malignant neoplasm of bronchus and lung. Over the analyzed years, the rate of newly diagnosed cases for male individuals has seen a decrease trend. Conversely, the rate of newly diagnosed cases for females has seen a steady increase over the years. This statistic shows the rate of newly diagnosed cases of lung cancer per 100,000 population in England from 1995 to 2022, by gender.

In 2022, 175 females per 100,000 population were registered in England as newly diagnosed with breast cancer. This was an overall increase in comparison to the last few years' rate of registration. This statistic shows the rate of newly diagnosed female cases of breast cancer per 100,000 population in England from 1995 to 2022.

In 2022, approximately 704.2 males per 100,000 and 562 females per 100,000 in England were newly diagnosed with cancer, excluding non-melanoma skin cancer. Overall, the diagnosis rate for both genders showed a slight increasing trend over the years. This statistic shows the rate of newly diagnosed cases of cancer per 100,000 population in England from 2019 to 2022, by gender.

Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.

This release summarises the diagnoses in 2019 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours)

Age-standardised rate of mortality from oral cancer (ICD-10 codes C00-C14) in persons of all ages and sexes per 100,000 population.RationaleOver the last decade in the UK (between 2003-2005 and 2012-2014), oral cancer mortality rates have increased by 20% for males and 19% for females1Five year survival rates are 56%. Most oral cancers are triggered by tobacco and alcohol, which together account for 75% of cases2. Cigarette smoking is associated with an increased risk of the more common forms of oral cancer. The risk among cigarette smokers is estimated to be 10 times that for non-smokers. More intense use of tobacco increases the risk, while ceasing to smoke for 10 years or more reduces it to almost the same as that of non-smokers3. Oral cancer mortality rates can be used in conjunction with registration data to inform service planning as well as comparing survival rates across areas of England to assess the impact of public health prevention policies such as smoking cessation.References:(1) Cancer Research Campaign. Cancer Statistics: Oral – UK. London: CRC, 2000.(2) Blot WJ, McLaughlin JK, Winn DM et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7. (3) La Vecchia C, Tavani A, Franceschi S et al. Epidemiology and prevention of oral cancer. Oral Oncology 1997; 33: 302-12.Definition of numeratorAll cancer mortality for lip, oral cavity and pharynx (ICD-10 C00-C14) in the respective calendar years aggregated into quinary age bands (0-4, 5-9,…, 85-89, 90+). This does not include secondary cancers or recurrences. Data are reported according to the calendar year in which the cancer was diagnosed.Counts of deaths for years up to and including 2019 have been adjusted where needed to take account of the MUSE ICD-10 coding change introduced in 2020. Detailed guidance on the MUSE implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/causeofdeathcodinginmortalitystatisticssoftwarechanges/january2020Counts of deaths for years up to and including 2013 have been double adjusted by applying comparability ratios from both the IRIS coding change and the MUSE coding change where needed to take account of both the MUSE ICD-10 coding change and the IRIS ICD-10 coding change introduced in 2014. The detailed guidance on the IRIS implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/impactoftheimplementationofirissoftwareforicd10causeofdeathcodingonmortalitystatisticsenglandandwales/2014-08-08Counts of deaths for years up to and including 2010 have been triple adjusted by applying comparability ratios from the 2011 coding change, the IRIS coding change and the MUSE coding change where needed to take account of the MUSE ICD-10 coding change, the IRIS ICD-10 coding change and the ICD-10 coding change introduced in 2011. The detailed guidance on the 2011 implementation is available at https://webarchive.nationalarchives.gov.uk/ukgwa/20160108084125/http://www.ons.gov.uk/ons/guide-method/classifications/international-standard-classifications/icd-10-for-mortality/comparability-ratios/index.htmlDefinition of denominatorPopulation-years (aggregated populations for the three years) for people of all ages, aggregated into quinary age bands (0-4, 5-9, …, 85-89, 90+)

BackgroundColorectal cancer incidence in the UK and other high-income countries has been increasing rapidly among young adults. This is the first analysis of colorectal cancer incidence trends by sub-site and socioeconomic deprivation in young adults in a European country.MethodsWe examined age-specific national trends in colorectal cancer incidence among all adults (20–99 years) diagnosed during 1971–2014, using Joinpoint regression to analyse data from the population-based cancer registry for England. We fitted a generalised linear model to the incidence rates, with a maximum of two knots. We present the annual percentage change in incidence rates in up to three successive calendar periods, by sex, age, deprivation and anatomical sub-site.ResultsAnnual incidence rates among the youngest adults (20–39 years) fell slightly between 1971 and the early 1990s, but increased rapidly from then onwards. Incidence Rates (IR) among adults 20–29 years rose from 0.8 per 100,000 in 1993 to 2.8 per 100,000 in 2014, an average annual increase of 8%. An annual increase of 8.1% was observed for adults aged 30–39 years during 2005–2014. Among the two youngest age groups (20–39 years), the average annual increase for the right colon was 5.2% between 1991 and 2010, rising to 19.4% per year between 2010 (IR = 1.2) and 2014 (IR = 2.5). The large increase in incidence rates for cancers of the right colon since 2010 were more marked among the most affluent young adults. Smaller but substantial increases were observed for cancers of the left colon and rectum. Incidence rates in those aged 50 years and older remained stable or decreased over the same periods.ConclusionsDespite the overall stabilising trend of colorectal cancer incidence in England, incidence rates have increased rapidly among young adults (aged 20–39 years). Changes in the prevalence of obesity and other risk factors may have affected the young population but more research is needed on the cause of the observed birth cohort effect. Extension of mass screening may not be justifiable due to the low number of newly diagnosed cases but clinicians should be alert to this trend.

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.

This publication reports on newly diagnosed cancers registered in England during 2021. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registrations (incidence) are provided by: Diagnosis (ICD-10 3-digit codes) by gender, age group, geographic region, deprivation and stage at diagnosis for selected cancer sites Diagnosis (ICD-10 4-digit code) by gender and age group

This statistic shows the number of registrations of newly diagnosed cases of ovarian cancer in England in 2022, by age group. The most affected age group was among 75 to 79 year olds, with 908 cases reported in 2022.

This data shows premature deaths (Age under 75) from all Cancers, numbers and rates by gender, as 3-year moving-averages. Cancers are a major cause of premature deaths. Inequalities exist in cancer rates between the most deprived areas and the most affluent areas. Directly Age-Standardised Rates (DASR) are shown in the data (where numbers are sufficient) so that death rates can be directly compared between areas. The DASR calculation applies Age-specific rates to a Standard (European) population to cancel out possible effects on crude rates due to different age structures among populations, thus enabling direct comparisons of rates. A limitation on using mortalities as a proxy for prevalence of health conditions is that mortalities may give an incomplete view of health conditions in an area, as ill-health might not lead to premature death. Data source: Office for Health Improvement and Disparities (OHID), indicator ID 40501, E05a. This data is updated annually.

The interactive Cancer Services profile tool has been updated to include the latest financial year of data that are available, collated by the National Disease Registration Service (NDRS). For most indicators, for example on screening, diagnostics and urgent suspected cancer referrals, the latest data is now available for the financial year 2023 to 2024. For the cancer incidence indicator, the tool has been updated to include the 2022 to 2023 data.

Legacy unique identifier: P00624

This dataset presents the mortality rate from cancer among individuals under the age of 75 within the Birmingham and Solihull area. It captures the number of deaths attributed to all cancers (classified under ICD-10 codes C00 to C97) and expresses this as a directly age-standardised rate per 100,000 population. The data is structured in quinary age bands and is available for both single-year and three-year rolling averages, providing a comprehensive view of premature cancer mortality trends in the region.

Rationale Reducing premature mortality from cancer is a key public health priority. This indicator helps track progress in lowering the number of cancer-related deaths among people under 75, supporting efforts to improve early diagnosis, treatment, and prevention strategies.

Numerator The numerator is the number of deaths from all cancers (ICD-10 codes C00 to C97) registered in the respective calendar years, for individuals aged under 75. These figures are aggregated into quinary age bands and sourced from the Death Register.

Denominator The denominator is the population of individuals under 75 years of age, also aggregated into quinary age bands. For single-year rates, the population for that year is used. For three-year rolling averages, the population-years are aggregated across the three years. The source of this data is the 2021 Census.

Caveats Data may not align exactly with published Office for National Statistics (ONS) figures due to differences in postcode lookup versions and the application of comparability ratios in Office for Health Improvement and Disparities (OHID) data. Users should be cautious when comparing this dataset with other national statistics.

External references Further information and related indicators can be found on the OHID Fingertips platform.

Localities ExplainedThis dataset contains data based on either the resident locality or registered locality of the patient, a distinction is made between resident locality and registered locality populations:Resident Locality refers to individuals who live within the defined geographic boundaries of the locality. These boundaries are aligned with official administrative areas such as wards and Lower Layer Super Output Areas (LSOAs).Registered Locality refers to individuals who are registered with GP practices that are assigned to a locality based on the Primary Care Network (PCN) they belong to. These assignments are approximate—PCNs are mapped to a locality based on the location of most of their GP surgeries. As a result, locality-registered patients may live outside the locality, sometimes even in different towns or cities.This distinction is important because some health indicators are only available at GP practice level, without information on where patients actually reside. In such cases, data is attributed to the locality based on GP registration, not residential address.

Click here to explore more from the Birmingham and Solihull Integrated Care Partnerships Outcome Framework.

In 2022, 55.8 males and 44.3 females per 100,000 population in England were registered as newly diagnosed with colon cancer. The rate of both females and males registered as newly diagnosed with colon cancer considerably decreased from the previous year. This statistic shows the rate of newly diagnosed cases of colon cancer per 100,000 population in England from 1995 to 2022, by gender.

Commentary, charts and tables present information on cancer cases and deaths in the UK. This publication has been discontinued as a result of the ONS Consultation on Statistical Products 2013. The last edition published was in December 2012. Source agency: Office for National Statistics Designation: National Statistics Language: English Alternative title: Cancer incidence and mortality

This bulletin presents the latest one- and five-year age-standardised net survival estimates for adults (aged 15-99 years) diagnosed in England with one of the 21 most common cancers. These cancers comprise over 90% of all newly diagnosed cancers. Source agency: Office for National Statistics Designation: National Statistics Language: English Alternative title: Cancer survival rates

This release summarises the survival of adults diagnosed with cancer in England between 2016 and 2020 and followed to 2021, and children diagnosed with cancer in England between 2002 and 2020 and followed to 2021. Adult cancer survival estimates are presented by age, deprivation, gender, stage at diagnosis, and geography.